Position in DYN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$245,441
+$23,604 QoQ
Shares Held
11,051
-9.7% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#166
of 245 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GUGGENHEIM CAPITAL LLC holds $210,403,156 across 75 Biotechnology names. DYN ranks #62 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
115,233 | $57,239,687 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
45,969 | $28,663,508 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
39,318 | $11,835,897 | |
| 4 | INCY |
Incyte Corp
|
57,780 | $6,549,940 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
26,474 | $4,958,050 | |
| 6 | INSM |
INSMED Inc
|
38,766 | $4,133,230 | |
| 7 | MRNA |
Moderna, Inc.
|
55,313 | $3,873,568 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
66,874 | $3,826,530 |
All Filings in DYN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $245,441 | 11,051 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $221,837 | 12,236 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $216,547 | 11,071 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $603,151 | 47,680 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $386,711 | 40,621 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $456,892 | 43,680 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $612,983 | 26,018 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,144,303 | 31,857 | Shares | Defined | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||